NCT03587194View on ClinicalTrials.gov

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions

Psoriasis

Interventions

DRUG

Otezla

Otezla 30mg BID

Trial Locations (1)

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

Sponsors

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

Psoriasis Treatment Center of Central New Jersey

OTHER